U.S. Food and Drug Administration · FDA enforcement report entry
FDA Class I: Baxter Healthcare Corporation — 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxte
The U.S. Food and Drug Administration listed this entry in its enforcement reports on September 9, 2026. The source link opens the FDA’s recalls, market withdrawals and safety alerts page.
Read the official source on fda.gov →
- Issued by
- U.S. Food and Drug Administration
- Document type
- FDA enforcement report entry
- Date
- First recorded by CourtPulse
- · all records that day
- Category
- FDA action
CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.